Australian biopharmaceutical company CSL Behring to invest $1.5B in Kankakee manufacturing facility
BRADLEY, Ill. — Australian biopharmaceutical company CSL introduced Monday a serious enlargement at its Kankakee manufacturing facility, a transfer that can carry end-to-end plasma processing into the U.S. CSL Behring, a subsidiary of CSL, mentioned it should invest $1.5 billion into the positioning enlargement by 2031, including 300 new high-skilled jobs to its present 1,200…